Gut microbiota and drug metabolism: the forgotten organ
International Journal of Experimental and Biomedical Research · 06.01.2026 · 5 (1) · 17-33
DOI: 10.26452/ijebr.v5i1.544 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Experimental and Biomedical Research, online erschienen am 06.01.2026. Verfasst von {"name":"Kamatham Udayasri","email":"udayasrikamatham@gmail.com","affiliation" und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The human gut microbiota, often termed the “forgotten organ,” plays a pivotal role in xenobiotic metabolism and significantly influences drug disposition, efficacy, and safety. While traditional pharmacokinetics and pharmacodynamics have emphasized hepatic and renal pathways, growing evidence shows that gut microbial enzymes can modify drug structures, alter absorption, and generate toxic metabolites. This review examines the mechanisms by which intestinal microbes metabolize therapeutic agents, highlightin g examples across major drug classes and outlining the clinical implications of microbiota – drug interactions. It also considers factors that modulate microbial activity — including diet, antibiotics, probiotics, and disease states — and how these variables aff ect pharmacokinetic parameters and therapeutic outcomes. Gut microbes perform diverse biotransformations such as reduction, hydrolysis, deconjugation, and methylation via enzymes including β - glucuronidase, azoreductase, and nitroreductase. These reactions may activate or inactivate drugs, thereby altering plasma concentrations, bioavailability, and adverse effect profiles. Clinical examples, such as the interaction between Eggerthella lenta and digoxin and β - glucuronidase – mediated irinotecan toxicity, demon strate the impact of microbiota variability on patient response. Integrating microbiome science with pharmacogenomics may advance personalized medicine and improve therapeutic safety.
Zitieren
APA
Udayasri","email":"udayasrikamatham@gmail.com","affiliation", N., Giridhar","email":"udayasrikamatham@gmail.com","affiliation", N., & Chandra","email":"udayasrikamatham@gmail.com","affi, N. P. (2026). Gut microbiota and drug metabolism: the forgotten organ. International Journal of Experimental and Biomedical Research, 5(1), 17-33. https://doi.org/10.26452/ijebr.v5i1.544
Vancouver
Udayasri","email":"udayasrikamatham@gmail.com","affiliation" N, Giridhar","email":"udayasrikamatham@gmail.com","affiliation" N, Chandra","email":"udayasrikamatham@gmail.com","affi NP. Gut microbiota and drug metabolism: the forgotten organ. International Journal of Experimental and Biomedical Research. 2026;5(1):17-33. doi:10.26452/ijebr.v5i1.544
BibTeX
@article{Udayasriemailudayasrikamathamgmailcomaffiliation2026,
author = {Udayasri","email":"udayasrikamatham@gmail.com","affiliation", "name":"Kamatham and Giridhar","email":"udayasrikamatham@gmail.com","affiliation", "name":"Achutha and Chandra","email":"udayasrikamatham@gmail.com","affi, "name":"Yadala Prapurna},
title = {Gut microbiota and drug metabolism: the forgotten organ},
journal = {International Journal of Experimental and Biomedical Research},
year = {2026},
volume = {5},
number = {1},
pages = {17--33},
doi = {10.26452/ijebr.v5i1.544}
}
EUVIMED